Following the success of 2022’s events, the Oncology Conference and the Precision Medicine Conference is BACK and running on two consecutive days. Join Bionow, expert speakers and industry colleagues to discuss the current oncology landscape on day one and the future of precision medicine on day two.
The prevention of cancer and the development of more effective strategies for early-stage detection, when treatment may be most effective, remain critical societal goals. Precision medicine is the next generation of healthcare research that has the potential to provide significant, targeted benefits to patients, and effect strategic shifts in the way healthcare is delivered. Bionow is pleased to once again present a two-day event to explore the relationship between these two areas of healthcare and facilitate a more in-depth programme, including talks, panel discussions and networking opportunities.
Oncology
The oncology portion of the conference will cover the issues surrounding prevention and early diagnosis, then discuss the latest advances to address these challenges and translate the science into better care for patients. We will hear from experts, organisations and patient advocacy groups.
Precision Medicine
The second day of the conference will focus on the impact precision medicine is having on patients in the detection, treatment and prevention of diseases and how we are developing this approach in an efficient and sustainable way. Topics will cover new diagnostic test development and the importance of biomarkers to enable the identification of the molecular cause of disease, and how this can support the development of novel, targeted treatments.
Organisations that attended the 2022 conferences:
Agile Life Sciences, Air Products, Ambit, Apex Molecular, Apis Assay Technologies Ltd, Aptamer Group, ATG Scientific Ltd, Biocair, BioPartner UK, Bivictrix, BMG Labtech, Cancer Research, Charles River, Chris Doherty, Cizzle Biotech, DXCOVER, FOx Biosystems, Hull University, Illumina, Keele University, Lancaster University, Lean Life Science, LS Law, Manchester Uni, Marks & Clerk, Medicines Discovery Catapult, Mills & Reeve, Monument Therapeutics, Nonacus, North West Cancer Research, Omecu, Pinpoint Data Solutions, QIAGEN, Sheffield University, Source BioScience, Spotlight Pathology, SRG, Sygnature Discovery, The University of Bradford, The University of Manchester, VOCAL, VRS Recruitment, Yourgene Health UK Ltd, Zilico
For further information on the exciting exhibitor opportunities available, check out the range of packages here. These WILL SELL OUT so secure your space now!
Call for posters
There is no better way to showcase new developments, ongoing research projects and speculative or innovative work in progress relating to the study of Oncology and Precision Medicine. Authors are invited to submit an abstract which is related to one or both of these areas.
The posters are intended to provide authors and participants with a greater understanding of the subject matter and to engage in discussions about the work.